We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock

Delisted

LUXA was delisted on the 28th of October, 2022.

57 hedge funds and large institutions have $228M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

704% more call options, than puts

Call options by funds: $6.34M | Put options by funds: $789K

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

16% more capital invested

Capital invested by funds: $197M → $228M (+$31.3M)

4% more funds holding

Funds holding: 5557 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
57
Holders Change
+2
Holders Change %
+3.64%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
8
Increased
18
Reduced
10
Closed
6
Calls
$6.34M
Puts
$789K
Net Calls
+$5.55M
Net Calls Change
+$3.63M
Name Holding Trade Value Shares
Change
Change in
Stake
ECP
1
Empyrean Capital Partners
California
$19.6M
WH
2
Wolfswood Holdings
New York
$19.6M
WAM
3
Weiss Asset Management
Massachusetts
$16.7M +$9.19M +933,215 +121%
SIG
4
Senator Investment Group
New York
$14.5M
Millennium Management
5
Millennium Management
New York
$12.6M +$988K +100,280 +8%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$12.2M
MA
7
MYDA Advisors
New York
$9.63M
BCM
8
Beryl Capital Management
California
$8.77M +$2.34M +237,999 +36%
RIA
9
RP Investment Advisors
Ontario, Canada
$8.19M +$8.22M +834,889 New
GCL
10
Glazer Capital LLC
New York
$7.82M -$313K -31,827 -4%
SRF
11
Silver Rock Financial
California
$7.13M +$219K +22,256 +3%
GL
12
Governors Lane
New York
$7.11M
CCA
13
Castle Creek Arbitrage
Colorado
$7.01M
BP
14
BBR Partners
New York
$6.28M
Marshall Wace
15
Marshall Wace
United Kingdom
$6.17M +$6.19M +628,947 New
FTCM
16
Fir Tree Capital Management
New York
$5.89M +$5.91M +600,366 New
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$5.87M +$3.22M +327,253 +121%
HI
18
HBK Investments
Texas
$5.4M
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
19
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.29M
Jane Street
20
Jane Street
New York
$3.36M +$63.5K +6,447 +2%
MF
21
Magnetar Financial
Illinois
$3.19M +$88K +8,933 +3%
Goldman Sachs
22
Goldman Sachs
New York
$2.8M -$1.16M -117,999 -29%
DCP
23
Diameter Capital Partners
New York
$2.51M
JP Morgan Chase
24
JP Morgan Chase
New York
$2.45M
UOC
25
UBS O'Connor
Illinois
$2.45M

LUXA Hedge Fund Activity: Q3 2021 in Review

57 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q3 2021, worth a combined $228M — up 16% from $197M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LUXA positions and 6 closed out — a net gain of 2 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Weiss Asset Management, adding an estimated $9.19M. The largest seller was Manulife (Manufacturers Life Insurance), exiting entirely with an estimated $5.16M sold.

  • 57 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q3 2021, up from 55 in Q2 2021.
  • Funds reported $228M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q3 2021, up 16% quarter-over-quarter.
  • 8 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q3 2021 and 6 closed out, a net change of +2 holders.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q3 2021 was Weiss Asset Management, an estimated $9.19M added.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q3 2021 was Manulife (Manufacturers Life Insurance), an estimated $5.16M sold.

Based on aggregated 13F filings for Q3 2021.